Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer
Authors
Keywords
Colorectal cancer, Exosomes, Prognosis, Histology, Vesicles, Immunohistochemistry techniques, Colon, Invasive tumors
Journal
PLoS One
Volume 14, Issue 2, Pages e0211564
Publisher
Public Library of Science (PLoS)
Online
2019-02-16
DOI
10.1371/journal.pone.0211564
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How cancer cells dictate their microenvironment: present roles of extracellular vesicles
- (2016) Yutaka Naito et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Expression of ODC Antizyme Inhibitor 2 (AZIN2) in Human Secretory Cells and Tissues
- (2016) Tiina Rasila et al. PLoS One
- IGFBP-rP1 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer
- (2015) S Zhu et al. Cell Death & Disease
- Epithelial-mesenchymal transition-associated secretory phenotype predicts survival in lung cancer patients
- (2014) A. K. Reka et al. CARCINOGENESIS
- High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival
- (2014) Qingqing Wang et al. MEDICAL ONCOLOGY
- Tetraspanins in Extracellular Vesicle Formation and Function
- (2014) Zoraida Andreu et al. Frontiers in Immunology
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Deregulation of Rab and Rab Effector Genes in Bladder Cancer
- (2012) Joel R. Ho et al. PLoS One
- Analysis of exosome release and its prognostic value in human colorectal cancer
- (2011) J. Silva et al. GENES CHROMOSOMES & CANCER
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features
- (2011) Erin S. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Evidence of a Role for Antizyme and Antizyme Inhibitor as Regulators of Human Cancer
- (2011) R. R. Olsen et al. MOLECULAR CANCER RESEARCH
- Ornithine decarboxylase antizyme inhibitor 2 regulates intracellular vesicle trafficking
- (2010) Kristiina Kanerva et al. EXPERIMENTAL CELL RESEARCH
- High expression of antizyme inhibitor 2, an activator of ornithine decarboxylase in steroidogenic cells of human gonads
- (2009) Laura T. Mäkitie et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Mammalian polyamine metabolism and function
- (2009) Anthony E. Pegg IUBMB LIFE
- The morphological and molecular features of the epithelial-to-mesenchymal transition
- (2009) Gema Moreno-Bueno et al. Nature Protocols
- Expression of Antizyme Inhibitor 2 in Mast Cells and Role of Polyamines as Selective Regulators of Serotonin Secretion
- (2009) Kristiina Kanerva et al. PLoS One
- Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index
- (2008) Katrin Hoffmann et al. BRITISH JOURNAL OF HAEMATOLOGY
- Enhanced Expression of Rab27A Gene by Breast Cancer Cells Promoting Invasiveness and the Metastasis Potential by Secretion of Insulin-Like Growth Factor-II
- (2008) J.-S. Wang et al. MOLECULAR CANCER RESEARCH
- Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase
- (2007) Kristiina Kanerva et al. BIOCHEMICAL JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started